Tag Archives: Pharmaceuticals
The Fund aims to address growing demand for high-quality healthcare services across North African and Sub-Saharan jurisdictions, through investments in high growth potential entities in three key sectors: specialized hospitals, medical diagnostics, and pharmaceuticals
The UN Economic Commission for Africa (ECA) argues that Uganda, like other African countries, needs to foster a higher level of industrial development to drive its economic transformation
Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa
JOHANNESBURG and PITTSBURGH /PRNewswire/ — Mylan Inc. (Nasdaq: MYL), one of the world’s leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products. South Africa has the world’s largest HIV/AIDS population, with approximately 5.6 million1 people living with the disease and an estimated 1.7 million2 people receiving treatment.
Standard Bank Group has been ranked 98 on the Global 100 Most Sustainable Corporations in the World list and is the only African company on the list. It’s also one of only nine banks listed. Its official ranking was announced at the World Economic Forum in Davos, Switzerland.
Mylan Selected As One of the Leading Suppliers to the South African National Department of Health 2013/2014 Antiretroviral Tender
JOHANNESBURG and PITTSBURGH, Nov. 29, 2012 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) announced today that its subsidiary in India, Mylan Laboratories Ltd., a leading manufacturer of antiretroviral (ARV) drugs, has been selected, through its South African-based subsidiary Mylan (Proprietary) Limited (Mylan Limited), as one of the leading suppliers of ARV drugs to the South African National Department of Health for the tender period January 1, 2013 to December 31, 2014.
Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets
CRANBURY, N.J. and CAMBRIDGE, Mass., Nov. 6, 2012 /PRNewswire/ — Oncobiologics, Inc. and Boston Oncology, LLC today announced a strategic partnership that will allow Boston Oncology to license, manufacture, and commercialize four of Oncobiologics’ biosimilar therapies for cancer and immunological disease in the Middle East and North African (MENA) regions.